{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:33:36Z","timestamp":1792132416421,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09706-6","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:14:22Z","timestamp":1762301662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of the neuromuscular manifestations in patients with IgG4-related disease: a systematic review"],"prefix":"10.1007","volume":"73","author":[{"given":"Renan Fabri","family":"Rosenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Pedro","family":"Baima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Ayres Mayrink","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Oliveira","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"9706_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020;72:7\u201319. https:\/\/doi.org\/10.1002\/art.41120.","journal-title":"Arthritis Rheumatol"},{"key":"9706_CR2","unstructured":"Wallace Z, Miles G, Smolkina E, Petruski-Ivleva N, Madziva D, Cook C, Fu X, Zhang Y, Stone J, Choi H. The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States [abstract]. Arthritis Rheumatol. 2022;74."},{"key":"9706_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/ard-2023-223950","volume":"82","author":"ZS Wallace","year":"2023","unstructured":"Wallace ZS, Miles G, Smolkina E, et al. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis. 2023;82:957\u201362. https:\/\/doi.org\/10.1136\/ard-2023-223950.","journal-title":"Ann Rheum Dis"},{"key":"9706_CR4","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/art.39686","volume":"68","author":"H Sekiguchi","year":"2016","unstructured":"Sekiguchi H, Horie R, Kanai M, et al. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016;68:2290\u20139. https:\/\/doi.org\/10.1002\/art.39686.","journal-title":"Arthritis Rheumatol"},{"key":"9706_CR5","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466\u201375. https:\/\/doi.org\/10.1002\/art.39205.","journal-title":"Arthritis Rheumatol"},{"key":"9706_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000680","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015. https:\/\/doi.org\/10.1097\/MD.0000000000000680.","journal-title":"Medicine (Baltimore)"},{"key":"9706_CR7","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology. 2015;54:1982\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/kev203.","journal-title":"Rheumatology"},{"key":"9706_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/401890","author":"D Inoue","year":"2012","unstructured":"Inoue D, Zen Y, Sato Y, et al. IgG4-related perineural disease. Int J Rheumatol. 2012. https:\/\/doi.org\/10.1155\/2012\/401890.","journal-title":"Int J Rheumatol"},{"key":"9706_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00776-013-0521-z","volume":"20","author":"JPY Cheung","year":"2015","unstructured":"Cheung JPY, Tsang HHL, Ho KWY, et al. Atypical manifestation of IgG4-related disease mimicking musculoskeletal infection. J Orthop Sci. 2015;20:574\u20138. https:\/\/doi.org\/10.1007\/s00776-013-0521-z.","journal-title":"J Orthop Sci"},{"key":"9706_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ncn3.12283","volume":"7","author":"T Konishi","year":"2019","unstructured":"Konishi T, Kohsaka M, Daifu M. A case of MuSK myasthenia gravis associated with solitary lymphadenopathy and insidious autoimmune-like diffuse encephalopathy. Neurol Clin Neurosci. 2019;7:203\u20135. https:\/\/doi.org\/10.1111\/ncn3.12283.","journal-title":"Neurol Clin Neurosci"},{"key":"9706_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/24725625.2020.1816675","volume":"5","author":"M Yoshikawa","year":"2021","unstructured":"Yoshikawa M, Muro Y, Ogawa-Momohara M, et al. A case with overlapping features of IgG4-related autoimmune pancreatitis, Sj\u00f6gren\u2019s syndrome and anti-aminoacyl-tRNA synthetase syndrome. Mod Rheumatol Case Rep. 2021;5:82\u20136. https:\/\/doi.org\/10.1080\/24725625.2020.1816675.","journal-title":"Mod Rheumatol Case Rep"},{"key":"9706_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"9706_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","volume":"31","author":"H Umehara","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31:529\u201333. https:\/\/doi.org\/10.1080\/14397595.2020.1859710.","journal-title":"Mod Rheumatol"},{"key":"9706_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392. https:\/\/doi.org\/10.1038\/modpathol.2012.72.","journal-title":"Mod Pathol"},{"key":"9706_CR15","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.clinph.2020.03.014","volume":"131","author":"R Dengler","year":"2020","unstructured":"Dengler R, de Carvalho M, Shahrizaila N, et al. AANEM \u2013 IFCN glossary of terms in neuromuscular electrodiagnostic medicine and ultrasound. Clin Neurophysiol. 2020;131:1662\u20133. https:\/\/doi.org\/10.1016\/j.clinph.2020.03.014.","journal-title":"Clin Neurophysiol"},{"key":"9706_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2169\/internalmedicine.51.6074","volume":"51","author":"N Ayuzawa","year":"2012","unstructured":"Ayuzawa N, Ubara Y, Keiichi S, et al. Churg-strauss syndrome with a clinical condition similar to IgG4-related kidney disease: a case report. Intern Med. 2012;51:1233\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.51.6074.","journal-title":"Intern Med"},{"key":"9706_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02069-z","volume":"21","author":"JB Bong","year":"2021","unstructured":"Bong JB, Lee DK, Lee MA, et al. Immunoglobulin G4-related disease presenting with peripheral neuropathy: a case report. BMC Neurol. 2021;21: 41. https:\/\/doi.org\/10.1186\/s12883-021-02069-z.","journal-title":"BMC Neurol"},{"key":"9706_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.lpm.2013.02.127","volume":"4036","author":"L Dudley","year":"2013","unstructured":"Dudley L, Brown L, Pettus J, et al. The association of granulomatosis with polyangiitis and IgG4-related disease: A case series. Presse Med. 2013;4036:491. https:\/\/doi.org\/10.1016\/j.lpm.2013.02.127.","journal-title":"Presse Med"},{"key":"9706_CR19","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2169\/internalmedicine.51.7725","volume":"51","author":"Y Hanioka","year":"2012","unstructured":"Hanioka Y, Yamagami K, Yoshioka K, et al. Churg-Strauss Syndrome Concomitant with Chronic Symmetrical Dacryoadenitis Suggesting Mikulicz\u2019s Disease. Intern Med. 2012;51:2457\u201361. https:\/\/doi.org\/10.2169\/internalmedicine.51.7725.","journal-title":"Intern Med"},{"key":"9706_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5414\/CN110547","volume":"96","author":"B Jiang","year":"2021","unstructured":"Jiang B, Sahenk Z, Satoskar A, et al. Vasculitic neuropathy associated with IgG4-related kidney disease: a case report and literature review. Clin Nephrol. 2021;96:175\u20138.","journal-title":"Clin Nephrol"},{"key":"9706_CR21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2169\/internalmedicine.55.5332","volume":"55","author":"M Kamiya","year":"2016","unstructured":"Kamiya M, Shane PY, Soejima M, et al. IgG4-related sialoadenitis with a skin lesion and multiple mononeuropathies suggesting coexistent cryoglobulinemic vasculitis. Intern Med. 2016;55:1355\u201361. https:\/\/doi.org\/10.2169\/internalmedicine.55.5332.","journal-title":"Intern Med"},{"key":"9706_CR22","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2169\/internalmedicine.6461-20","volume":"60","author":"T Kawazoe","year":"2021","unstructured":"Kawazoe T, Inoue T, Tobisawa S, et al. Immunoglobulin G4-related disease accompanied by peripheral neuropathy: a report of two cases. Intern Med. 2021;60:1941\u20137. https:\/\/doi.org\/10.2169\/internalmedicine.6461-20.","journal-title":"Intern Med"},{"key":"9706_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.5692\/clinicalneurol.54.1047","volume":"54","author":"K Ohyama","year":"2014","unstructured":"Ohyama K, Koike H, Takahashi M, et al. Clinicopathological features of neuropathy associated with IgG4-related disease. Rinsho Shinkeigaku. 2014;54:1047\u20139. https:\/\/doi.org\/10.5692\/clinicalneurol.54.1047.","journal-title":"Rinsho Shinkeigaku"},{"key":"9706_CR24","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.ekir.2023.02.159","volume":"8","author":"W Papanrueng","year":"2023","unstructured":"Papanrueng W, Thammavaranucupt K. WCN23-0564 overlap ANCA-associated glomerulonephritis and IGG4-related kidney disease: a case report and literature review. Kidney Int Rep. 2023;8:S72. https:\/\/doi.org\/10.1016\/j.ekir.2023.02.159.","journal-title":"Kidney Int Rep"},{"key":"9706_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5692\/clinicalneurol.cn-000835","volume":"56","author":"Y Suzuki","year":"2016","unstructured":"Suzuki Y, Shiraishi M, Yamada K, et al. A case of refractory IgG4-related peripheral neuropathy with severe axonal damage. Rinsho Shinkeigaku. 2016;56:323\u20137. https:\/\/doi.org\/10.5692\/clinicalneurol.cn-000835.","journal-title":"Rinsho Shinkeigaku"},{"key":"9706_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/thoraxjnl-2018-212692","volume":"74","author":"S Zhang","year":"2019","unstructured":"Zhang S, Zhang S, Zhang W, et al. Pulmonary inflammatory myofibroblastic tumour and IgG 4 -related disease presenting with lower limb paralysis. Thorax. 2019;74:313\u20134.","journal-title":"Thorax"},{"key":"9706_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000066","author":"W Waheed","year":"2015","unstructured":"Waheed W, Nickerson J, Ambaye AB, et al. IgG4-related neuromyopathy associated with recurrent pleural effusion. J Clin Neuromuscul Dis. 2015. https:\/\/doi.org\/10.1097\/CND.0000000000000066.","journal-title":"J Clin Neuromuscul Dis"},{"key":"9706_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/cns.13747","volume":"28","author":"CC Wang","year":"2022","unstructured":"Wang CC, Liu B, Li XL, et al. Chronic inflammatory demyelinating polyneuropathy-like neuropathy in IgG4-related disease. CNS Neurosci Ther. 2022;28:172\u20134.","journal-title":"CNS Neurosci Ther"},{"key":"9706_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.11213\/tonyobyo.60.75","volume":"60","author":"S Adachi","year":"2017","unstructured":"Adachi S, Tamai H, Tojikubo M, et al. A Case of IgG4-Related Disease Associated With Poor Glycemic Control and Enlarged Submandibular Glands in a Type 2 Diabetes Patient. J Japan Diab Socy. 2017;60:75\u201382. https:\/\/doi.org\/10.11213\/tonyobyo.60.75.","journal-title":"J Japan Diab Socy"},{"key":"9706_CR30","unstructured":"Alba MA, Milisenda J, Fern\u00e1ndez S, Garc\u00eda-Herrera A, Hern\u00e1ndez-Rodr\u00edguez J, Grau JM, Campo E, Cid MC. Small-vessel vasculitis with prominent IgG4 positive plasma cell infiltrates as potential part of the spectrum of IgG4-related disease: a case report. Clin Exp Rheumatol. 2015;33(2 Suppl 89):S-138\u201341."},{"key":"9706_CR31","doi-asserted-by":"crossref","unstructured":"Baig MT, Satoskar AA, Jiang B, et al. IgG4-Related Kidney Disease Associated with an Unusual Vasculitic Peripheral Neuropathy Session Information. Kidney Week 2020. 2020.","DOI":"10.1681\/ASN.20203110S1550d"},{"key":"9706_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12026-022-09279-8","volume":"70","author":"D Faz-Mu\u00f1oz","year":"2022","unstructured":"Faz-Mu\u00f1oz D, Hinojosa-Azaola A, Mej\u00eda-Vilet JM, et al. ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review. Immunol Res. 2022;70:550\u20139. https:\/\/doi.org\/10.1007\/s12026-022-09279-8.","journal-title":"Immunol Res"},{"key":"9706_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-41","author":"M Fujii","year":"2014","unstructured":"Fujii M, Sato Y, Ohara N, et al. Systemic IgG4-related disease with extensive peripheral nerve involvement that progressed from localized IgG4-related lymphadenopathy: an autopsy case. Diagn Pathol. 2014. https:\/\/doi.org\/10.1186\/1746-1596-9-41.","journal-title":"Diagn Pathol"},{"key":"9706_CR34","doi-asserted-by":"publisher","DOI":"10.1159\/000525908","author":"M Tarisawa","year":"2022","unstructured":"Tarisawa M, Kano T, Tanaka D, et al. IgG4-related peripheral neuropathy with unilateral cervical nerve root and brachial plexus swelling: a case report. Case Rep Neurol. 2022. https:\/\/doi.org\/10.1159\/000525908.","journal-title":"Case Rep Neurol"},{"key":"9706_CR35","unstructured":"Baldelli E. BE, CPS, CF, MM, GCS, PA, FM. Lambert-Eaton myasthenic syndrome and igg4-related disease: a possible novel association. XVIII Congress of the Italian Association of Myology. 2018:9\u201397."},{"key":"9706_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/1538574416678557","volume":"50","author":"H Jun","year":"2016","unstructured":"Jun H, Jung CW. Immunoglobulin G4-related inflammatory abdominal aortic aneurysm associated with myasthenia gravis, with contained rupture. Vasc Endovascr Surg. 2016;50:571\u20134. https:\/\/doi.org\/10.1177\/1538574416678557.","journal-title":"Vasc Endovascr Surg"},{"key":"9706_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.86.16_supplement.P3.134","volume":"86","author":"P Raibagkar","year":"2016","unstructured":"Raibagkar P, Stone J. To report the first case of muscle specific tyrosine kinase (MuSK) antibody (ab) positive myasthenia gravis (MG) evolving into immunoglobulin (Ig) G4 related disease (P3.134). Neurology. 2016;86: P3.134. https:\/\/doi.org\/10.1212\/WNL.86.16_supplement.P3.134.","journal-title":"Neurology"},{"key":"9706_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008710","author":"R Anan","year":"2017","unstructured":"Anan R, Akiyama M, Kaneko Y, et al. Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: a case report and literature review. Medicine (Baltimore). 2017. https:\/\/doi.org\/10.1097\/MD.0000000000008710.","journal-title":"Medicine (Baltimore)"},{"key":"9706_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2018.11.009","volume":"29","author":"V Casteleyn","year":"2019","unstructured":"Casteleyn V, Radbruch H, Diekhoff T, et al. Immunoglobulin (Ig)g-4 related myositis \u2013 a new entity? Neuromuscul Disord. 2019;29:70\u20134. https:\/\/doi.org\/10.1016\/j.nmd.2018.11.009.","journal-title":"Neuromuscul Disord"},{"key":"9706_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00256-019-03250-9","volume":"49","author":"M Creze","year":"2001","unstructured":"Creze M, Boussebaa S, Lazure T, et al. IgG4-related disease: rare presentation as a soft-tissue mass in the thigh of an adolescent. Skeletal Radiol. 2001;49:155\u201360. https:\/\/doi.org\/10.1007\/s00256-019-03250-9.","journal-title":"Skeletal Radiol"},{"key":"9706_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1346-8138.12141","volume":"40","author":"K Ito","year":"2013","unstructured":"Ito K, Imafuku S, Hamaguchi Y, et al. Case report of anti-transcription intermediary factor-1-\u03b3\/\u03b1 antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor. J Dermatol. 2013;40:567\u20139. https:\/\/doi.org\/10.1111\/1346-8138.12141.","journal-title":"J Dermatol"},{"issue":"12","key":"9706_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/ijcm.2013.412a1001","volume":"04","author":"DS Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez DS, Oliva FL, Fern\u00e1ndez Ace\u00f1ero MJ, et al. Igg4-related disease presenting as a soft tissue tumor affecting skeletal muscle: a case report. Int J Clin Med. 2013;04(12):1\u20134. https:\/\/doi.org\/10.4236\/ijcm.2013.412a1001.","journal-title":"Int J Clin Med"},{"key":"9706_CR43","unstructured":"MC Zlatescu MALAATSV. Inflammatory focal myositis with IgG4 infiltrate in a patient with rheumatoid arthritis: a case report. 48th Annual Congress of the Canadian Neurological Sciences Federation. 2013:S1\u201361."},{"key":"9706_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab669","volume":"61","author":"H Morf","year":"2022","unstructured":"Morf H, Roemer F, Agaimy A, et al. IgG4-related fasciitis. Rheumatology. 2022;61: e11. https:\/\/doi.org\/10.1093\/rheumatology\/keab669.","journal-title":"Rheumatology"},{"key":"9706_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.nmd.2023.04.004","volume":"33","author":"SC Suresh","year":"2023","unstructured":"Suresh SC, Hasan A, Zonnoor SL, et al. Can IgG4-related disease present as isolated myositis? Neuromuscul Disord. 2023;33:570\u20134. https:\/\/doi.org\/10.1016\/j.nmd.2023.04.004.","journal-title":"Neuromuscul Disord"},{"key":"9706_CR46","doi-asserted-by":"publisher","first-page":"PA1140","DOI":"10.1183\/13993003.congress-2018.PA1140","volume":"52","author":"N Thakkar","year":"2018","unstructured":"Thakkar N, Nene A. Immunoglobulin G4-related pneumonitis and myositis: an atypical presentation of an atypical case. Eur Respir J. 2018;52:PA1140. https:\/\/doi.org\/10.1183\/13993003.congress-2018.PA1140.","journal-title":"Eur Respir J"},{"key":"9706_CR47","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/qjmed\/hcz195","volume":"112","author":"M-K Tsai","year":"2019","unstructured":"Tsai M-K, Kuo C-W, Chang L-C. IgG4-related myositis. QJM: An Int J Medne. 2019;112:872\u20133. https:\/\/doi.org\/10.1093\/qjmed\/hcz195.","journal-title":"QJM: An Int J Medne"},{"key":"9706_CR48","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1111\/1346-8138.15330","volume":"47","author":"K Yokoi","year":"2020","unstructured":"Yokoi K, Nakagawa Y, Akome J, et al. Case of immunoglobulin G4-related disease presenting with an intramuscular mass. J Dermatol. 2020;47:e219\u201320.","journal-title":"J Dermatol"},{"key":"9706_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7:86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x.","journal-title":"Nat Rev Dis Primers"},{"key":"9706_CR50","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","volume":"128","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Comarmond C, Domont F, et al. Cryoglobulinemia vasculitis. Am J Med. 2015;128:950\u20135. https:\/\/doi.org\/10.1016\/j.amjmed.2015.02.017.","journal-title":"Am J Med"},{"key":"9706_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65:270\u201381. https:\/\/doi.org\/10.1002\/art.37721.","journal-title":"Arthritis Rheum"},{"key":"9706_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488. https:\/\/doi.org\/10.1136\/ard.2010.137778.","journal-title":"Ann Rheum Dis"},{"key":"9706_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","volume":"83","author":"B Hellmich","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83: 30. https:\/\/doi.org\/10.1136\/ard-2022-223764.","journal-title":"Ann Rheum Dis"},{"key":"9706_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00257","author":"L Oni","year":"2019","unstructured":"Oni L, Sampath S. Childhood IgA vasculitis (Henoch Schonlein purpura)\u2014advances and knowledge gaps. Front Pediatr. 2019. https:\/\/doi.org\/10.3389\/fped.2019.00257.","journal-title":"Front Pediatr"},{"key":"9706_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103093","volume":"139","author":"J Rohmer","year":"2023","unstructured":"Rohmer J, Nguyen Y, Trefond L, et al. Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: data from 196 patients. J Autoimmun. 2023;139: 103093. https:\/\/doi.org\/10.1016\/j.jaut.2023.103093.","journal-title":"J Autoimmun"},{"key":"9706_CR56","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force\u2014second revision. Eur J Neurol. 2021;28:3556\u201383. https:\/\/doi.org\/10.1111\/ene.14959.","journal-title":"Eur J Neurol"},{"key":"9706_CR57","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R, et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 2014;82:879\u201386. https:\/\/doi.org\/10.1212\/WNL.0000000000000205.","journal-title":"Neurology"},{"key":"9706_CR58","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","volume":"2","author":"H Ogata","year":"2015","unstructured":"Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol. 2015;2:960\u201371. https:\/\/doi.org\/10.1002\/acn3.248.","journal-title":"Ann Clin Transl Neurol"},{"key":"9706_CR59","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y, et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology. 2016;86:800\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000002418.","journal-title":"Neurology"},{"key":"9706_CR60","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura Y, Devaux JJ, Fukami Y, et al. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 2015;138:1484\u201391. https:\/\/doi.org\/10.1093\/brain\/awv054.","journal-title":"Brain"},{"key":"9706_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01029","author":"A Vural","year":"2018","unstructured":"Vural A, Doppler K, Meinl E. Autoantibodies against the Node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01029.","journal-title":"Front Immunol"},{"key":"9706_CR62","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the guidelines of the German Neurological Society. J Neurol. 2016;263:1473\u201394. https:\/\/doi.org\/10.1007\/s00415-016-8045-z.","journal-title":"J Neurol"},{"key":"9706_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis. Nat Rev Dis Primers. 2019;5: 30. https:\/\/doi.org\/10.1038\/s41572-019-0079-y.","journal-title":"Nat Rev Dis Primers"},{"key":"9706_CR64","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"T Rispens","year":"2023","unstructured":"Rispens T, Huijbers MG. The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol. 2023;23:763\u201378. https:\/\/doi.org\/10.1038\/s41577-023-00871-z.","journal-title":"Nat Rev Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09706-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:30:52Z","timestamp":1770190252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9706"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09706-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}